Inventiva Sa (NASDAQ: IVA) — Healthcare · Share Price, Chart & Market Data
About: Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.15 (-1.15%)
IVAInventiva Sa
Loading watchlist status…
Trade IVA now
Inventiva Sa share price
IVA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:28 am GMT+0
IVA price performance
-7.871%
5D
-14.452%
1M
8.193%
YTD
36.605%
1Y
IVA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:28 am GMT+0
IVA Market Signals